Page last updated: 2024-11-06

menfegol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

menfegol: vaginal contraceptive tablet containing 60 mg Menphegol; active ingedient is a surface active agent known as p-menthanylphenyl polyoxyethylene ether also called TS-88 or menphegal; structure in UD 25:18h [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65408
MeSH IDM0093443

Synonyms (6)

Synonym
ts 88
menfegol
2-[4-(2-methyl-5-propan-2-ylcyclohexyl)phenoxy]ethanol
38193-77-0
DTXSID00959120
2-{4-[2-methyl-5-(propan-2-yl)cyclohexyl]phenoxy}ethan-1-ol

Research Excerpts

Overview

Menfegol is a spermicide with in vitro activity against human immunodeficiency virus (HIV)

ExcerptReferenceRelevance
"Menfegol is a spermicide with in vitro activity against human immunodeficiency virus (HIV). "( Frequent use of menfegol spermicidal vaginal foaming tablets associated with a high incidence of genital lesions.
Belsey, E; Goeman, J; Karam, M; Laga, M; Lange, JM; Mboup, S; Ndoye, I; Perriƫns, JH; Piot, P; Sakho, LM, 1995
)
2.08

Toxicity

ExcerptReferenceRelevance
" This study indicates that the regular and proper use of OVT-n or OVT-m tablets are comparable and are a safe means of birth control."( A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol-9 versus menfegol) in Thai women.
Chompootaweep, S; Dusitsin, N, 1990
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (66.67)18.7374
1990's4 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.49 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (42.86%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]